Journal
CLINICAL INFECTIOUS DISEASES
Volume 67, Issue 5, Pages 795-798Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciy279
Keywords
dalbavancin; endocarditis; Gram-positive infection
Categories
Ask authors/readers for more resources
The clinical outcomes and safety of dalbavancin as primary and sequential treatment of gram-positive bacteremia with infective endocarditis were evaluated retrospectively. The clinical success rate was high (92.6%), but in 24 of 27 patients dalbavancin was used only after clearance of bacteria from the bloodstream.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available